200,000+ products from a single source!
sales@angenechem.com
Home > Indoles and Oxindole > 712-09-4
712-09-4 | 2-(5-Methoxy-1H-indol-3-yl)ethanol
CAS No: 712-09-4 Catalog No: AG005K9D MDL No:MFCD00047196
Product Description
Catalog Number:
AG005K9D
Chemical Name:
2-(5-Methoxy-1H-indol-3-yl)ethanol
CAS Number:
712-09-4
Molecular Formula:
C11H13NO2
Molecular Weight:
191.2264
MDL Number:
MFCD00047196
IUPAC Name:
2-(5-methoxy-1H-indol-3-yl)ethanol
InChI:
InChI=1S/C11H13NO2/c1-14-9-2-3-11-10(6-9)8(4-5-13)7-12-11/h2-3,6-7,12-13H,4-5H2,1H3
InChI Key:
QLWKTGDEPLRFAT-UHFFFAOYSA-N
SMILES:
OCCc1c[nH]c2c1cc(OC)cc2
EC Number:
211-919-3
Properties
Complexity:
186
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
191.095g/mol
Formal Charge:
0
Heavy Atom Count:
14
Hydrogen Bond Acceptor Count:
2
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
191.23g/mol
Monoisotopic Mass:
191.095g/mol
Rotatable Bond Count:
3
Topological Polar Surface Area:
45.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.8
Literature
| Title | Journal |
|---|---|
| Melatonin and synthetic melatonergic agonists: actions and metabolism in the central nervous system. | Central nervous system agents in medicinal chemistry 20120901 |
| Effects of power frequency electromagnetic fields on melatonin and sleep in the rat. | Emerging health threats journal 20120101 |
| Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction. | TheScientificWorldJournal 20120101 |
| 6-methoxytryptophol reduces lipopolysaccharide-induced lipid peroxidation in vitro more effectively than melatonin. | Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20111201 |
| Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept. | Translational psychiatry 20110701 |
| Measurement of melatonin in body fluids: standards, protocols and procedures. | Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 20110601 |
| Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value. | International journal of Alzheimer's disease 20110101 |
| Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same? | Clinical & developmental immunology 20110101 |
| Significance of high levels of endogenous melatonin in Mammalian cerebrospinal fluid and in the central nervous system. | Current neuropharmacology 20100901 |
| Melatonin metabolism in the central nervous system. | Current neuropharmacology 20100901 |
| Clinical aspects of melatonin intervention in Alzheimer's disease progression. | Current neuropharmacology 20100901 |
| Melatonin and structurally-related compounds protect synaptosomal membranes from free radical damage. | International journal of molecular sciences 20100101 |
| Circulating Antibodies to IDO/THO Pathway Metabolites in Alzheimer's Disease. | International journal of Alzheimer's disease 20100101 |
| Effects of naphthalene, beta-naphthoflavone and benzo(a)pyrene on the diurnal and nocturnal indoleamine metabolism and melatonin content in the pineal organ of rainbow trout, Oncorhynchus mykiss. | Aquatic toxicology (Amsterdam, Netherlands) 20090402 |
| Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders. | CNS neuroscience & therapeutics 20090101 |
| New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists. | Neuropsychiatric disease and treatment 20090101 |
| Simultaneous liquid chromatographic measurement of melatonin and related indoles through post-column electrochemical demethylation and fluorescence derivatization. | Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20060201 |
| Melatonin in Alzheimer's disease and other neurodegenerative disorders. | Behavioral and brain functions : BBF 20060101 |
| Indoleamines and 5-methoxyindoles in trout pineal organ in vivo: daily changes and influence of photoperiod. | General and comparative endocrinology 20051001 |
| Analytical chemistry of synthetic routes to psychoactive tryptamines. Part I. Characterisation of the Speeter and Anthony synthetic route to 5-methoxy-N,N-diisopropyltryptamine using ESI-MS-MS and ESI-TOF-MS. | The Analyst 20041101 |
| Daily variation in the concentration of melatonin and 5-methoxytryptophol in the goose pineal gland, retina, and plasma. | General and comparative endocrinology 20031201 |
| Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites. | Journal of pharmacological sciences 20031201 |
| Mutagenesis studies of the human MT2 melatonin receptor. | Biochemical pharmacology 20030715 |
| Melatonin and 5-methoxytryptophol (5-ML) in nervous and/or neurosensory structures of a gastropod mollusc (Helix aspersa maxima): synthesis and diurnal rhythms. | General and comparative endocrinology 20030401 |
| Photoperiod affects amplitude but not duration of in vitro melatonin production in the ruin lizard (Podarcis sicula). | Journal of biological rhythms 20030201 |
| Total pineal endocrine substitution therapy (TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic solid tumor patients: a phase II study. | Neuro endocrinology letters 20030101 |
| Photochemical properties of kynurenine pathway metabolites and indoleamines. | Advances in experimental medicine and biology 20030101 |
| Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain. | Journal of neurochemistry 20021001 |
| Demonstration of antifungal and anti-human immunodeficiency virus reverse transcriptase activities of 6-methoxy-2-benzoxazolinone and antibacterial activity of the pineal indole 5-methoxyindole-3-acetic acid. | Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20020601 |
| Daily variation in the concentration of 5-methoxytryptophol and melatonin in the duck pineal gland and plasma. | Journal of pineal research 20020501 |
| 2[125I]Iodomelatonin binding sites in guinea pig platelets. | Journal of pineal research 20020301 |
| Conversion of L-tryptophan to serotonin and melatonin in human melanoma cells. | FEBS letters 20020130 |
| The effect of copper on (3H)-tryptophan metabolism in organ cultures of rat pineal glands. | Metabolic brain disease 20011201 |
| Examination of pineal indoles and 6-methoxy-2-benzoxazolinone for antioxidant and antimicrobial effects. | Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20011101 |
| Serine residues 110 and 114 are required for agonist binding but not antagonist binding to the melatonin MT(1) receptor. | Biochemical and biophysical research communications 20010420 |
| Pineal indoles stimulate the gene expression of immunomodulating cytokines. | Journal of neural transmission (Vienna, Austria : 1996) 20010101 |
| Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. | The Journal of biological chemistry 19990507 |
| Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: molecular modeling and inhibition studies. | Journal of medicinal chemistry 19930430 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.